Brief: Cleveland Biolabs Says Co Received Notice Of Delisting From Nasdaq
23/08/2019 21:27
Aug 23 (Reuters) - Cleveland Biolabs Inc CBLI.O :
* CLEVELAND BIOLABS INC - RECEIVED NOTICE OF DELISTING OR
FAILURE
TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM NASDAQ
Source text: (http://bit.ly/33TglNc)
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc